🟢 Cerenome is trading 6.55% up today with no confirmed catalyst

Cerenome is trading 6.55% up now at $1.79, with no confirmed catalyst identified for the October 21 move.

• On October 21, Cerenome announced new preclinical REYOBIQ findings, including improved antitumor activity when combined with anti-PD-1; the company did not link the data to the share-price move.
• Healthcare-sector strength and rotation away from technology were reported October 20, providing broader context, not a confirmed explanation for this session’s gain.
• No trading-volume information was available.